相关实验视频

Updated: Mar 12, 2026

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

针对胃肠道癌的双特异性T细胞诱导疗法

Kyle A Burton¹, Anastasia E Metropulos², Suneel D Kamath³

¹Department of Medicine, University of Wisconsin, Madison, WI, USA.

|March 10, 2026

概括

双特异性T细胞参与者对胃肠道 (GI) 癌症有希望,克服了免疫治疗的局限性. 研究正在探索它们在治疗这些困难瘤方面的潜力和挑战.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
胃肠病学胃肠病学

背景情况:

癌症免疫疗法已取得显著的进步,但在胃肠道 (GI) 癌症中表现出有限的成功.
双特异性T细胞参与者 (BiTEs) 已成为一个有前途的治疗策略,在血液恶性瘤中显示出有效性.
双TEs向CD3和瘤特异性抗原,使T细胞介导的抗瘤活性独立于MHC限制或TCR特异性.

研究的目的:

综合总结目前对两种特异性T细胞参与肠道癌症的临床和临床前研究.
探索BITE在胃肠道瘤治疗中的潜在治疗益处.
讨论在胃肠道瘤学中与BTE相关的潜在障碍和毒性.

主要方法:

审查当前的临床和临床前研究对二特异性T细胞参与肠道癌症.
对促进抗瘤细胞毒性的BTE作用机制的分析.
识别和讨论在肠道瘤学中对BTE的挑战和安全考虑.

主要成果:

双特异性T细胞参与剂为克服常规免疫疗法在肠道癌症中的局限性提供了一种新的方法.
对将BiTEs的成功从血液恶性瘤转化为胃肠道瘤存在显著兴趣.
目前正在进行的研究正在评估BiTE在各种胃肠道癌症环境中的有效性和安全性.

结论:

双特异性T细胞参与剂在改善胃肠道癌症治疗结果方面具有相当大的潜力.
需要进一步的研究和临床试验,以充分阐明BITE在肠道瘤学中的有效性和管理潜在的毒性.
解决治疗有效性的障碍对于成功实施BTE在肠道癌症治疗中至关重要.

关键词:

双特异性T细胞参与者.胃肠道癌症是什么意思免疫治疗是一种免疫疗法.瘤免疫学瘤免疫学

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...